Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.

Suppr

超能文献

作者信息

Abdelhalim Ahmed, Barcos Maurice, Block Annemarie W, Sait Sheila N J, Starostik Petr, Wetzler Meir, Wang Eunice S

出版信息

Leuk Lymphoma. 2007 May;48(5):1053-6. doi: 10.1080/10428190701258370.

DOI:10.1080/10428190701258370

PMID:17487757

Abstract

摘要

相似文献

Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.

Leuk Lymphoma. 2007 May;48(5):1053-6. doi: 10.1080/10428190701258370.

Systemic dasatinib fails to prevent development of central nervous system progression in a patient with BCR-ABL unmutated Philadelphia chromosome-positive leukemia.

Blood. 2009 May 14;113(20):5028-9. doi: 10.1182/blood-2008-11-191080.

Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid.

Leuk Lymphoma. 2013 Jul;54(7):1557-9. doi: 10.3109/10428194.2012.745933. Epub 2012 Dec 22.

Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.

Philadelphia-negative clonal hematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukemia.

Blood. 2007 Oct 15;110(8):3086-7. doi: 10.1182/blood-2007-05-092437.

Dasatinib maintenance therapy after allogeneic hematopoietic stem cell transplantation for an isolated central nervous system blast crisis in chronic myelogenous leukemia.

Acta Haematol. 2013;130(2):111-4. doi: 10.1159/000347158. Epub 2013 Mar 29.

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.

Blood. 2008 Aug 15;112(4):1005-12. doi: 10.1182/blood-2008-02-140665. Epub 2008 May 13.

[Dasatinib is an efficient therapy for central nervous system Philadelphia chromosome-positive mixed phenotype acute leukemia].

Zhonghua Xue Ye Xue Za Zhi. 2014 Nov;35(11):1016-7. doi: 10.3760/cma.j.issn.0253-2727.2014.11.015.

[Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):581-6. doi: 10.7534/j.issn.1009-2137.2013.03.009.

[Pharmacological properties and clinical efficacy of dasatinib hydrate (Sprycel), an anticancer drug for chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia].

Nihon Yakurigaku Zasshi. 2009 Sep;134(3):159-67. doi: 10.1254/fpj.134.159.

引用本文的文献

Non-conducting functions of ion channels: The case of integrin-ion channel complexes.

Channels (Austin). 2022 Dec;16(1):185-197. doi: 10.1080/19336950.2022.2108565.

Primary Testicular and Cutaneous Philadelphia Chromosome Positive B-Cell Lymphoblastic Lymphoma: A Rare Case and Review.

Cancer Manag Res. 2022 Apr 21;14:1507-1514. doi: 10.2147/CMAR.S353022. eCollection 2022.

Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer's disease.

Cell Death Dis. 2018 Jul 26;9(8):820. doi: 10.1038/s41419-018-0886-1.

Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report.

Oncol Lett. 2015 Apr;9(4):1957-1961. doi: 10.3892/ol.2015.2928. Epub 2015 Feb 3.

Philadelphia chromosome-positive acute lymphoblastic leukemia with extramedullary and meningeal relapse after allogeneic hematopoietic stem cell transplantation that was successfully treated with dasatinib.

Springerplus. 2014 Apr 5;3:177. doi: 10.1186/2193-1801-3-177. eCollection 2014.

Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib.

Onco Targets Ther. 2009 Feb 18;2:83-94. doi: 10.2147/ott.s3971.

Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.

Biologics. 2007 Dec;1(4):433-48.

Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Expert Rev Anticancer Ther. 2009 Mar;9(3):331-56. doi: 10.1586/14737140.9.3.331.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验